Go to:
Logótipo
You are in:: Start > Publications > View > Effect of subcutaneous administration of RTX in the spared nerve injury model of neurophatic pain
Map of Premises
FC6 - Departamento de Ciência de Computadores FC5 - Edifício Central FC4 - Departamento de Biologia FC3 - Departamento de Física e Astronomia e Departamento GAOT FC2 - Departamento de Química e Bioquímica FC1 - Departamento de Matemática
Publication

Effect of subcutaneous administration of RTX in the spared nerve injury model of neurophatic pain

Title
Effect of subcutaneous administration of RTX in the spared nerve injury model of neurophatic pain
Type
Poster in an International Conference
Year
2010
Authors
Daniel Pozza
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Conference International
FENS forum
Amsterdam
Scientific classification
FOS: Medical and Health sciences > Other medical sciences
Other information
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies (2015)
Another Publication in an International Scientific Journal
Costa Monteiro, IDC; Madureira, P; de Vasconscelos, A; Daniel Pozza; de Mello, RA
Introduction to vimentin and novel approaches (2013)
Another Publication in an International Scientific Journal
Daniel Pozza; De Mello, RA
Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice? (2020)
Another Publication in an International Scientific Journal
De Mello, RA; Zhu, JH; Iavelberg, J; Potim, AH; Simonetti, D; Silva, JA; Castelo Branco, P; Daniel Pozza; Tajima, CC; Tolia, M; Antoniou, G
Comparative cost-effectiveness analysis of avelumab plus axitinib versus pembrolizumab plus axitinib, ipilimumab plus nivolumab, and sunitnib for advanced renal cell carcinoma in the UK Perspective (2020)
Another Publication in an International Scientific Journal
De Mello, RA; Ayoub, E; Castelo Branco, P; De Almeida Zia, VAD; Savio, A; Daniel Pozza; Tadokoro, H; Teich, N

See all (115)

Recommend this page Top
Copyright 1996-2026 © Faculdade de Ciências da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2026-02-17 at 02:21:26 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book